Hronic Eosinophilic Esophagitis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA approves Dupixent for pediatric patients with chronic eosinophilic esophagitis, expanding treatment options for children as young as 1 year old.

Naimish patelPediatric patientsHronic eosinophilic esophagitisFda approvalImmune system diseaseUnmet needsPthe fda